EW
DXCM icon

Evoke Wealth’s DexCom DXCM Stock Holding History

Evoke Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,304
Closed -$459K – 180
2026
Q1 		$459K Sell
7,304
-97
-1% -$6.75K 0.01% 426
2025
Q4 		$491K Buy
7,401
+944
+15% +$61K 0.01% 394
2025
Q3 		$434K Sell
6,457
-464
-7% -$36.7K 0.01% 400
2025
Q2 		$604K Buy
+6,921
New +$542K 0.01% 309
2022
Q4 		– Sell
-996
Closed -$80K – 591
2022
Q3 		$80K Sell
996
-257
-21% -$21.8K ﹤0.01% 446
2022
Q2 		$93K Sell
1,253
-647
-34% -$59K ﹤0.01% 422
2022
Q1 		$243K Buy
1,900
+352
+23% +$38.5K 0.01% 317
2021
Q4 		$208K Sell
1,548
-8
-0.5% -$1.15K 0.01% 358
2021
Q3 		$212K Sell
1,556
-192
-11% -$24.2K 0.01% 334
2021
Q2 		$187K Buy
1,748
+1,668
+2,085% +$160K 0.01% 357
2021
Q1 		$7K Buy
80
+48
+150% +$4.51K ﹤0.01% 760
2020
Q4 		$3K Hold
32
– – ﹤0.01% 813
2020
Q3 		$3K Hold
32
– – ﹤0.01% 763
2020
Q2 		$3K Buy
+32
New +$2.86K ﹤0.01% 781

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Evoke Wealth's DXCM Position: Q2 2026 in Review

Evoke Wealth sold out of DexCom (DXCM) in Q2 2026, closing a stake of 7,304 shares — an estimated $459K sold.

Evoke Wealth first reported a position in DXCM in Q2 2020 and held it in 14 quarters. The position peaked at $604K in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Evoke Wealth reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 7,304 DexCom shares in Q2 2026, an estimated $459K.
  • Evoke Wealth first reported a position in DexCom in Q2 2020 and held it in 14 quarters.
  • Evoke Wealth's DexCom position peaked at $604K in Q2 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.